References

• Peirce V, Carobbio S, Vidal-Puig A. The different shades of fat. Nature. 2014;510(7503):76-83. google scholar
• Lidell ME. Brown adipose tissue in human infants. Handb Exp Pharmacol. 2019;251:107-123. google scholar
• Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009;360(15):1518-1525. google scholar
• Cypess AM, White AP, Vernochet C, et al. Anatomical localiza-tion, gene expression profiling and functional characterization of adult human neck brown fat. Nature Med. 2013;19(5):635-639. google scholar
• van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009;360(15):1500-1508. google scholar
• Kir S, White JP, Kleiner S, et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature. 2014;513(7516):100-104. google scholar
• Petruzzelli M, Schweiger M, Schreiber R, et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 2014;20(3):433-447. google scholar
• Kir S, Spiegelman BM. Cachexia and brown fat: A burning issue in cancer. Trends Cancer. 2016;2(9):461-463. google scholar
• Cohen P, Spiegelman BM. Brown and beige fat: Molecular parts of a thermogenic machine. Diabetes. 2015;64(7):2346-2351. google scholar
• Kir S, Komaba H, Garcia AP, et al. PTH/PTHrP receptor mediates cachexia in models of kidney failure and cancer. Cell Metab. 2016;23(2):315-323. google scholar
• Cuevas-Ramos D, Mehta R, Aguilar-Salinas CA. Fibroblast growth factor 21 and browning of white adipose tissue. Front Physiol. 2019;10:37. doi:10.3389/fphys.2019.00037 google scholar
• Szczepanska E, Gietka-Czernel M. FGF21: A Novel regulator of glucose and lipid metabolism and whole-body energy balance. Horm Metab Res. 2022;54(4):203-211. google scholar
• Lu W, Li X, Luo Y. FGF21 in obesity and cancer: New insights. Cancer Lett. 2021;499:5-13. google scholar
• Chartoumpekis DV, Habeos IG, Ziros PG, Psyrogiannis AI, Kyri-azopoulou VE, Papavassiliou AG. Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. Mol Med. 2011;17(7-8):736-740. google scholar
• Fisher FM, Kleiner S, Douris N, et al. FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012;26(3):271-281. google scholar
• Abu-Odeh M, Zhang Y, Reilly SM, et al. FGF21 promotes ther-mogenic gene expression as an autocrine factor in adipocytes. Cell Rep. 2021;35(13):109331. doi:10.1016/j.celrep.2021.109331 google scholar
• Keipert S, Kutschke M, Ost M, et al. Long-term cold adaptation does not require FGF21 or UCP1. Cell Metab. 2017;26(2):437-446 e5. doi:10.1016/j.cmet.2017.07.016 google scholar
• Beenken A, Mohammadi M. The FGF family: Biology, patho-physiology and therapy. Nat Rev Drug Discov. 2009;8(3):235-253. google scholar
• Hui Q, Jin Z, Li X, Liu C, Wang X. FGF family: From drug de-velopment to clinical application. Int J Mol Sci. 2018;19(7):1875. doi:10.3390/ijms19071875 google scholar
• Li X. The FGF metabolic axis. Front Med. 2019;13(5):511-530. google scholar
• Bilgic SN, Domaniku A, Toledo B, et al. EDA2R-NIK signalling promotes muscle atrophy linked to cancer cachexia. Nature. 2023;617(7962):827-834. google scholar
• Tan H, Yue T, Chen Z, Wu W, Xu S, Weng J. Targeting FGF21 in cardiovascular and metabolic diseases: From mechanism to medicine. Int J Biol Sci. 2023;19(1):66-88. google scholar
• Dolegowska K, Marchelek-Mysliwiec M, Nowosiad-Magda M, Slawinski M, Dolegowska B. FGF19 subfamily members: FGF19 and FGF21. J Physiol Biochem. 2019;75(2):229-240. google scholar
• Harmer NJ. Insights into the role of heparan sulphate in fibroblast growth factor signalling. Biochem Soc Trans. 2006;34(Pt 3):442-445. google scholar
• Kwon MM, O’Dwyer SM, Baker RK, Covey SD, Kieffer TJ. FGF21-mediated improvements in glucose clearance require un-coupling protein 1. Cell Rep. 2015;13(8):1521-1527. google scholar
• Keipert S, Lutter D, Schroeder BO, et al. Author Correction: Endogenous FGF21-signaling controls paradoxical obesity resis-tance of UCP1-deficient mice. Nat Commun. 2021;12(1):1804. doi:10.1038/s41467-021-22119-x google scholar
• Charoenphandhu N, Suntornsaratoon P, Krishnamra N, et al. Fi-broblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats. J Bone Miner Metab. 2017;35(2):142-149. google scholar
• Sun Y, Wang R, Zhao S, et al. FGF9 inhibits browning program of white adipocytes and associates with human obesity. J Mol Endocrinol. 2019;62(2):79-90. google scholar
• Li H, Zhang X, Huang C, et al. FGF2 disruption enhances thermogenesis in brown and beige fat to protect against adi-posity and hepatic steatosis. Mol Metab. 2021;54:101358. doi:10.1016/j.molmet.2021.101358 google scholar
• Shamsi F, Xue R, Huang TL, et al. FGF6 and FGF9 regulate UCP1 expression independent of brown adipogenesis. Nat Commun. 2020;11(1):1421. doi:10.1038/s41467-020-15055-9 google scholar
• Goetz R, Ohnishi M, Kir S, et al. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor. The J Biol Chem. 2012;287(34):29134-29146. google scholar
• Zhao L, Niu J, Lin H, et al. Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases. EBioMedicine. 2019;48:462-477. google scholar

Citations